Keywords: 1st, qtr, net, income, up, ares-serono, swiss
1st qtr net income up 111% at Ares-Serono
Article | 30 April 1999
Swiss drugs group Ares-Serono reported a 93.2% rise in operating incomeand 111.3% in net earnings for the first quarter of 1999, to $56.3 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
